Entheo.Ai builds AI-powered tools that enhance safety and integration for entheogenic experiences while also offering AI integration services for businesses. Their product suite includes Psychedelic AI guides, the PsiloScreen prescreening tool that instantly generates a PsiloScore, and CDC pipelines that provide real‑time AI access to relational databases without disrupting existing workflows. By combining user affect detection, intention analysis, and specialized data pipelines, Entheo.Ai enables seamless, intelligent AI transformation for both mental‑health and enterprise applications.
Funding
Funding not disclosed
Founders
Product
Problem
Individuals seeking entheogenic experiences often lack reliable tools to assess personal safety, dosage suitability, and integration support, leading to increased risk of adverse reactions and suboptimal therapeutic outcomes. Simultaneously, businesses aiming to adopt AI face challenges integrating advanced models into existing legacy systems without disrupting workflows.
Solution
Entheo.Ai offers a suite of AI-driven products that support safe preparation, screening, and integration of psychedelic experiences, including instant PsiloScore generation, genetic sensitivity analysis, and a research-trained chatbot for guidance. For enterprises, the company designs custom AI integration services such as real-time Change Data Capture (CDC) pipelines, Pinecone tokenization, and affect/intention detection, enabling seamless AI access to relational databases and legacy architectures. These solutions combine domain-specific knowledge with scalable AI infrastructure, allowing users and organizations to benefit from intelligent risk assessment and data-driven insights without extensive reengineering.
Target Audience
Primary users include individuals planning psychedelic journeys, mental health professionals, and entheogenic coaches; enterprise customers are businesses and developers seeking to embed AI capabilities into legacy or cloud-based data systems.
Features
- PsiloScreen prescreening tool that instantly calculates a PsiloScore to evaluate suitability for psilocybin use
- Entheogenic Sensitivity Screening that analyzes genetic profiles to predict individual responses to various entheogens
- MushGPT chatbot trained on hundreds of psychedelic research papers for real-time safety and integration advice
- Entheo.Pro toolkit providing AI resources tailored for entheogenic coaches and mental health practitioners
- Confidential Laboratory Information Management System for secure analytical testing data exchange
- CDC pipelines delivering real-time AI access to relational databases while preserving existing workflow integrity
- Pinecone-based AI tokenization and user affect/intention detection modules for advanced personalization
- Custom AI solution development for risk screening, knowledge retrieval, and personalized recommendation engines